Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-01

Clinical Trial Update: The Effect of BIA 2-093 on the Steady-state Pharmacodynamic and Pharmacokinetic Profiles of Warfarin [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the effect of BIA 2-093 on the steady-state pharmacodynamic and pharmacokinetic profiles of warfarin, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BIA 2-093
  • Warfarin (warfarin)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2014-12-01